|Other Names||Calcipressin-3, Down syndrome candidate region 1-like protein 2, Myocyte-enriched calcineurin-interacting protein 3, MCIP3, Regulator of calcineurin 3, RCAN3, DSCR1L2|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development (By similarity).|
|Tissue Location||Highest expression in heart, skeletal muscle kidney, liver and peripheral blood leukocytes. Lower expression in all other tissues|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
RCAN3 inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development (By similarity).
Sales, K.J., et al. Biochim. Biophys. Acta 1793(12):1917-1928(2009)Enjuanes, A., et al. Cancer Res. 68(24):10178-10186(2008)Facchin, F., et al. Gene 407 (1-2), 159-168 (2008) :Mulero, M.C., et al. Biochim. Biophys. Acta 1773(3):330-341(2007)Olsen, J.V., et al. Cell 127(3):635-648(2006)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.